| Accession Number | 0001140361-26-010932 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 24, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Mar 20, 2026 | Exercise/Conversion | 76,224 | $1.18 | $89,944.32 | 84,661 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 20, 2026 | Exercise/Conversion | 23,776 | $1.50 | $35,664.00 | 108,437 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 20, 2026 | Sale | 100,000 | $3.55 | $355,000.00 | 8,437 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Mar 20, 2026 | Exercise/Conversion | 76,224 | $0.00 | $0.00 | 38,136 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Mar 20, 2026 | Exercise/Conversion | 23,776 | $0.00 | $0.00 | 734,139 | Direct | โ | View Details |